The isolation of tumour-initiating cells from human melanomas is reported, with preliminary evidence suggesting that these melanoma stem cells can be specifically targeted with antibodies targeted against ABCB5, which offers a potential therapeutic strategy against melanomas.
- Tobias Schatton
- George F. Murphy
- Markus H. Frank